Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma
BMC cancer, Volume 16, Issue 1, 2016, Pages 464
WOS
Keywords:
Paclitaxel Maximum Tolerate Dose Dose Cohort Granulocyte Colony Stimulate Factor Treatment Metastatic Nasopharyngeal Carcinoma
Abstract:
ClinicalTrials.gov ID: NCT01735409 . The trial was registered on November 20th, 2012.
Code:
Data:
Tags
Comments